Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cymetra.

Brian P Maloney1, Brent A Murphy, Harvey P Cole

  • 1The Maloney Center for Facial Plastic Surgery, Atlanta, Georgia, USA.

Facial Plastic Surgery : FPS
|January 12, 2005
PubMed
Summary
This summary is machine-generated.

Injectable acellular human dermal matrix (Cymetra) acts as a temporary scaffold for soft tissue replacement. It encourages natural tissue growth and revascularization, offering promising clinical applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osseous metaplasia of the eyelid: report of 2 cases.

Ophthalmic plastic and reconstructive surgery·2013
Same author

Lip augmentation: discussion and debate.

Facial plastic surgery clinics of North America·2012
See all related articles

Area of Science:

  • Biomaterials science
  • Regenerative medicine
  • Tissue engineering

Background:

  • Soft tissue replacement is crucial in reconstructive surgery.
  • Temporary scaffolds can promote host tissue regeneration.
  • Acellular human dermal matrix (Alloderm) has demonstrated efficacy in tissue regeneration.

Purpose of the Study:

  • To review the manufacturing process of micronized acellular human dermal matrix (Cymetra).
  • To examine the tissue interaction and clinical applications of Cymetra.
  • To discuss the anticipated clinical outcomes of using Cymetra for soft tissue replacement.

Main Methods:

  • Review of manufacturing data for Cymetra.
  • Analysis of preclinical and clinical studies on Alloderm and Cymetra.

Related Experiment Videos

  • Synthesis of existing literature on tissue integration and revascularization.

    • Main Results:

    • Cymetra is an injectable form of acellular human dermal matrix.
    • Observed tissue ingrowth and revascularization in implanted Alloderm sheets.
    • Demonstrated potential for Cymetra in various clinical applications.

    Conclusions:

    • Micronized acellular human dermal matrix (Cymetra) shows potential as a filler for soft tissue regeneration.
    • The injectable form facilitates easier delivery and broader clinical use.
    • Further clinical evaluation is warranted to confirm long-term efficacy and safety.